Cargando…

At the Crossroads of Cardiac Beta-Adrenergic Receptor Signaling and Myocardial Glucose Metabolism

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Kereliuk, Stephanie M., Koch, Walter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322861/ https://www.ncbi.nlm.nih.gov/pubmed/37426537 http://dx.doi.org/10.1016/j.jacbts.2023.02.016

Ejemplares similares

Renal denervation: are we at a crossroads?
por: Voskuil, M.
Publicado: (2016)

Blood pressure and glaucoma: At the crossroads between cardiology and ophthalmology
por: Skrzypecki, Janusz, et al.
Publicado: (2019)

Negative Adrenergic Feedback Specific to Phospholamban
por: Hasenfuss, Gerd, et al.
Publicado: (2017)

Endothelial caveolin at the crossroad of thrombo-inflammation coupling
por: ElAli, Ayman
Publicado: (2022)

Fuziline Ameliorates Glucose and Lipid Metabolism by Activating Beta Adrenergic Receptors to Stimulate Thermogenesis
por: Gao, He, et al.
Publicado: (2023)

The opioid crisis and the 2020 US election: crossroads for a national epidemic
por: Wen, Leana S, et al.
Publicado: (2020)

Metabolic Syndrome and Myocardial Contractile Reserve
por: Kim, Seong Hwan
Publicado: (2011)

Beta-Adrenergic gene therapy for cardiovascular disease
por: Eckhart, Andrea D, et al.
Publicado: (2000)

Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism
por: van der Wall, E. E., et al.
Publicado: (2010)

β-agonists for ARDS: the dark side of adrenergic stimulation?
por: Thompson, B Taylor
Publicado: (2012)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Cardiac arrest during vigorous exercise: coronary plaque rupture or myocardial ischaemia?
por: van Rosendael, Alexander R., et al.
Publicado: (2015)

Crossroad
por: Paz-Pacheco, Elizabeth
Publicado: (2022)

Decoding the Complex Crossroad of Tryptophan Metabolic Pathways
por: Mondanelli, Giada, et al.
Publicado: (2022)

HIV Treatment-As-Prevention Research: Taking the Right Road at the Crossroads
por: Hayes, Richard, et al.
Publicado: (2015)

Connecting the Dots for Connective Tissue Growth Factor Roles in Cardiac Wound Healing After Myocardial Infarction
por: Hale, Taben M., et al.
Publicado: (2019)

Refueling the Failing Heart: A Case for Sodium-Glucose Cotransporter 2 Inhibition in Cardiac Energy Homeostasis
por: Crawford, Peter A.
Publicado: (2018)

Comment on Katsarelias, D., et al. “The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study” Cancers 2020, 12, 3228
por: de Giorgi, Vincenzo, et al.
Publicado: (2020)

New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
por: de Lucia, Claudio, et al.
Publicado: (2018)

Is education at the crossroads?
por: Tomlins, Ron
Publicado: (2013)

Neurology at the crossroads
Publicado: (2020)

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
por: quốc Lu’o’ng, Khanh vinh, et al.
Publicado: (2012)

Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2
por: Cannavo, Alessandro, et al.
Publicado: (2019)

Therapeutic Treatment Approaches Post–Myocardial Infarction: A Bias Toward Formyl Peptide Receptor Agonists
por: Zaman, Rysa, et al.
Publicado: (2019)

Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling
por: Zhang, Zheng, et al.
Publicado: (2014)

Modulation of Glucagon Signaling: A Metabolic Approach for Heart Failure?
por: Pocai, Alessandro
Publicado: (2019)

Improving Left Ventricular Myocardial Function After Myocardial Infarction: Is it in the BAG?
por: McTiernan, Charles F.
Publicado: (2016)

Crossroads in Medical Computing
por: Cohen, R. D.
Publicado: (1981)

Sleeping Sickness at the Crossroads
por: Burri, Christian
Publicado: (2020)

Metabolic Reprogramming After Left Ventricular Assist Device: Remodeling Without Recovery of Cardiac Energetics
por: Rame, J. Eduardo, et al.
Publicado: (2016)

The Role of Beta-Adrenergic Receptors in Depression and Resilience
por: Zhang, Hongxing, et al.
Publicado: (2022)

Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts
por: Carter, Rhonda L, et al.
Publicado: (2014)

Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy
por: Cannavo, Alessandro, et al.
Publicado: (2013)

Contrast nephropathy: Risk factors and the role of beta blockers
por: Bowden, Rodney G.
Publicado: (2015)

Acute myocardial infarction in the elderly
por: Zijlstra, F., et al.
Publicado: (2015)

INCREASED BETA2-ADRENERGIC RECEPTOR SIGNALING ENHANCES PROGRESSION OF HEPATOCELLULAR CARCINOMA
por: Pizzini, Jason, et al.
Publicado: (2019)

Beta3-Adrenergic Receptor Activation Alleviates Cardiac Dysfunction in Cardiac Hypertrophy by Regulating Oxidative Stress
por: Zhang, Mingming, et al.
Publicado: (2021)

β-Adrenergic receptor signaling in cardiac function and heart failure
por: Madamanchi, Aasakiran
Publicado: (2007)

Searching for the key to improve infarcted cardiac wall motion and prevent ventricular remodeling after ST-segment elevation myocardial infarction: Beyond symptom-onset-to-balloon time
por: Jeong, Myung Ho
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_roihr4f6551cp69lh3ekfa2ha0